Risdiplam

Overview

Risdiplam is an orally available SMN2 pre-mRNA splicing modifier used for the treatment of spinal muscular atrophy (SMA).

Application

Products > Drug Discovery > Inhibitor | Products > Drug Discovery > Inhibitor | Cancer | Survival Motor Neuron (SMN)

Product Information

• Catalog No.: B2693-346655
• CAS No.: 1825352-65-5
• Molecular Formula: C22H23N7O
• Molecular Weight: 401.5

Source

Original product source